TY  - RPRT
TI  - The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response Mechanisms
AU  - Wang, J.
AU  - Macoritto, M.
AU  - Guay, H.
AU  - Davis, J. W.
AU  - Levesque, M. C.
AU  - Cao, X.
PY  - 2022
DO  - 10.1101/2022.05.16.492167
UR  - https://www.biorxiv.org/content/10.1101/2022.05.16.492167v1
ID  - 10.1101/2022.05.16.492167
ER  -